| Acronym | EPND |
|---|
| Status | Active |
|---|
| Effective start/end date | 1/11/2021 → 31/10/2026 |
|---|
- King's College London
- AC Immune
- Deutsches Zentrum Fur Neurodegenerative Erkrankungen EV
- Janssen Pharmaceutica N.V.
- F. Hoffmann-La Roche AG
- University Medical Center Groningen
- Luxembourg Institute of Health
- University of Gothenburg
- Takeda Pharmaceuticals International
- Teva Pharmaceutical Industries Ltd
- Maastricht University (lead)
- University of Geneva
- Sanofi-Aventis Recherche & Development
- UCB Biopharma SPRL (UCB SA)
- University of Luxembourg
- Amsterdam UMC
- Academisch Ziekenhuis Groningen
- Aridhia Informatics Ltd
- Stichting Lygature
- Novartis Pharma AG
- University of Leicester
- University of Oxford
- Centre Hospitalier Universitaire Vaudois
- EC European Commission: £130,526.27